Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Breast Cancer

Free Subscription 14.09.2020 2 AJR Am J Roentgenol 1 Ann Surg 1 Ann Surg Oncol 3 BMC Cancer 3 Breast Cancer 1 Breast Cancer Res 6 Breast Cancer Res Treat 4 Breast J 1 Cancer Cell 1 Cancer Lett 1 Carcinogenesis 2 Clin Breast Cancer 1 Clin Cancer Res 1 Eur Radiol 1 Gene 1 Int J Radiat Oncol Biol Phys 2 J Clin Oncol 1 J Natl Cancer Inst 1 Lancet Oncol 1 Nature 1 PLoS Genet 2 PLoS One 2 Radiology 1 Semin Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. DIBBLE EH, Hunt KN, Ehman EC, O'Connor MK, et al
   Molecular Breast Imaging in Clinical Practice.
   AJR Am J Roentgenol. 2020 Jun 17:1-8. doi: 10.2214/AJR.19.22622.
   PubMed         Abstract available
   
   
2. MORI N, Sheth D, Abe H
   Nonmass Enhancement Breast Lesions: Diagnostic Performance of Kinetic Assessment on Ultrafast and Standard Dynamic Contrast-Enhanced MRI in Comparison With Morphologic Evaluation.
   AJR Am J Roentgenol. 2020 May 26:1-8. doi: 10.2214/AJR.19.21920.
   PubMed         Abstract available
   
   

   
   Ann Surg

3. POULSON MR, Beaulieu-Jones BR, Kenzik KM, Dechert TA, et al
   Residential Racial Segregation and Disparities in Breast Cancer Presentation, Treatment, and Survival.
   Ann Surg. 2020 Sep 1. doi: 10.1097/SLA.0000000000004451.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

4. STAFFORD A, Williams A, Edmiston K, Cocilovo C, et al
   Axillary Response in Patients Undergoing Neoadjuvant Endocrine Treatment for Node-Positive Breast Cancer: Systematic Literature Review and NCDB Analysis.
   Ann Surg Oncol. 2020 Sep 9. pii: 10.1245/s10434-020-08905.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. BAKSHI D, Nagpal A, Sharma V, Sharma I, et al
   MassARRAY-based single nucleotide polymorphism analysis in breast cancer of north Indian population.
   BMC Cancer. 2020;20:861.
   PubMed         Abstract available
   
   
6. DAVIE A, Carter GC, Rider A, Pike J, et al
   Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2- advanced breast cancer in five European countries.
   BMC Cancer. 2020;20:855.
   PubMed         Abstract available
   
   
7. BAKKACH J, Mansouri M, Derkaoui T, Loudiyi A, et al
   Contribution of BRCA1 and BRCA2 germline mutations to early onset breast cancer: a series from north of Morocco.
   BMC Cancer. 2020;20:859.
   PubMed         Abstract available
   
   

   
   Breast Cancer

8. ROGOZA-JANISZEWSKA E, Malinska K, Gorski B, Scott RJ, et al
   Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population.
   Breast Cancer. 2020 Sep 4. pii: 10.1007/s12282-020-01151.
   PubMed         Abstract available
   
   
9. AKRIDA I, Argentou MI
   Correction to: Letter to the Editor: comment on 'Breast-conserving surgery with intraoperative radiotherapy in recurrent breast cancer: the patient's perspective' by Elfgen et al.
   Breast Cancer. 2020 Sep 8. pii: 10.1007/s12282-020-01154.
   PubMed         Abstract available
   
   
10. ALATAWI Y, Hansen RA, Chou C, Qian J, et al
    The impact of cognitive impairment on survival and medication adherence among older women with breast cancer.
    Breast Cancer. 2020 Sep 9. pii: 10.1007/s12282-020-01155.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res

11. BERTRAND KA, Bethea TN, Gerlovin H, Coogan PF, et al
    Aspirin use and risk of breast cancer in African American women.
    Breast Cancer Res. 2020;22:96.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res Treat

12. CHEN R, Ma G, Xia T
    Letter to the editor with regard to the manuscript titled "Circulating tumour cell enumeration does not correlate with Miller-Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy".
    Breast Cancer Res Treat. 2020 Sep 4. pii: 10.1007/s10549-020-05886.
    PubMed        
    
    
13. CHA C, Lee J, Kim D, Park S, et al
    Comparison of resection margin status after single or double radiopaque marker insertion for tumor localization in breast cancer patients receiving neoadjuvant chemotherapy.
    Breast Cancer Res Treat. 2020 Sep 9. pii: 10.1007/s10549-020-05907.
    PubMed         Abstract available
    
    
14. HISOSHIMA M, Urano M, Ohashi K, Ogawa M, et al
    Utility of 70-kV single-energy CT in depicting the extent of breast cancer for preoperative planning.
    Breast Cancer Res Treat. 2020 Sep 10. pii: 10.1007/s10549-020-05909.
    PubMed         Abstract available
    
    
15. ALTUNDAG K
    HER2-positivity in mucinous cancer might be related to accompanying infiltrating ductal carcinoma histology.
    Breast Cancer Res Treat. 2020;180:829.
    PubMed        
    
    
16. NEVEN P, Froyman W, Timmerman S, Timmerman D, et al
    Uterine ultrasound and endometrial biopsy in tamoxifen users.
    Breast Cancer Res Treat. 2020;180:833-834.
    PubMed        
    
    
17. KO NY, Qureshi MM, Oladeru OT, Cassidy MR, et al
    Racial differences in genomic testing and receipt of endocrine therapy in early-stage breast cancer.
    Breast Cancer Res Treat. 2020 Sep 4. pii: 10.1007/s10549-020-05888.
    PubMed         Abstract available
    
    

    
    Breast J

18. ACEA-NEBRIL B, Garcia-Novoa A, Garcia-Jimenez L, Escribano-Posada C, et al
    Impact of the COVID-19 pandemic on a breast cancer surgery program. Observational case-control study in a COVID-free hospital.
    Breast J. 2020 Sep 7. doi: 10.1111/tbj.14037.
    PubMed        
    
    
19. GERLACH K, Phalak K, Patel M, Leung JWT, et al
    COVID-19: Current and future crisis planning in breast imaging.
    Breast J. 2020;26:1615-1617.
    PubMed        
    
    
20. TESTORI A, Alloisio M, Errico V, Perroni G, et al
    Extraordinary emergency measures set up by a Breast Unit to prevent COVID-19: Report of our experience.
    Breast J. 2020;26:1611-1612.
    PubMed        
    
    
21. SORBO G, Gagliano S, La Tessa C, Ferrarini R, et al
    Breast unit Efficacy with the relocation of the surgical breast team during the COVID-19 pandemic.
    Breast J. 2020;26:1613-1614.
    PubMed        
    
    

    
    Cancer Cell

22. ARRUABARRENA-ARISTORENA A, Maag JLV, Kittane S, Cai Y, et al
    FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer.
    Cancer Cell. 2020 Aug 25. pii: S1535-6108(20)30414.
    PubMed         Abstract available
    
    

    
    Cancer Lett

23. RONG Y, Huang LX, Yi KZ, Chen H, et al
    Co-administration of sulforaphane and doxorubicin attenuates breast cancer growth by preventing the accumulation of myeloid-derived suppressor cells.
    Cancer Lett. 2020 Sep 3. pii: S0304-3835(20)30455.
    PubMed         Abstract available
    
    

    
    Carcinogenesis

24. N HAINES C, Klingensmith HD, Komara M, Burd CJ, et al
    GREB1 regulates PI3K/Akt signaling to control hormone-sensitive breast cancer proliferation.
    Carcinogenesis. 2020 Sep 7. pii: 5902307. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

25. FILIPE MD, van Deukeren D, Kip M, Doeksen A, et al
    Effect of the COVID-19 Pandemic on Surgical Breast Cancer Care in the Netherlands: A Multicenter Retrospective Cohort Study.
    Clin Breast Cancer. 2020 Aug 7. pii: S1526-8209(20)30207.
    PubMed         Abstract available
    
    
26. GOFF SL, Danforth DN
    The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer.
    Clin Breast Cancer. 2020 Jul 2. pii: S1526-8209(20)30155.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

27. TOLANEY SM, Im YH, Calvo E, Lu YS, et al
    Phase Ib Study of Ribociclib Plus Fulvestrant and Ribociclib Plus Fulvestrant Plus PI3K-Inhibitor (Alpelisib or Buparlisib) for HR+ Advanced Breast Cancer.
    Clin Cancer Res. 2020 Sep 4. pii: 1078-0432.CCR-20-0645.
    PubMed         Abstract available
    
    

    
    Eur Radiol

28. MENG N, Wang X, Sun J, Han D, et al
    A comparative study of the value of amide proton transfer-weighted imaging and diffusion kurtosis imaging in the diagnosis and evaluation of breast cancer.
    Eur Radiol. 2020 Sep 4. pii: 10.1007/s00330-020-07169.
    PubMed         Abstract available
    
    

    
    Gene

29. ZHANG XY, Mao L
    Circular RNA Circ_0000442 Acts as a Sponge of MiR-148b-3p to Suppress Breast Cancer via PTEN/PI3K/Akt Signaling Pathway.
    Gene. 2020 Sep 3:145113. doi: 10.1016/j.gene.2020.145113.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

30. GOODMAN C, Speers CW
    The role of circulating tumor cells in breast cancer and implications for radiation treatment decisions.
    Int J Radiat Oncol Biol Phys. 2020 Aug 31. pii: S0360-3016(20)34134.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

31. OFFERSEN BV, Alsner J, Nielsen HM, Jakobsen EH, et al
    Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial.
    J Clin Oncol. 2020 Sep 10:JCO2001363. doi: 10.1200/JCO.20.01363.
    PubMed         Abstract available
    
    
32. THOMSEN AR, Vaupel P, Grosu AL, Notter M, et al
    Hyperthermia Plus Re-Irradiation in the Management of Unresectable Locoregional Recurrence of Breast Cancer in Previously Irradiated Sites.
    J Clin Oncol. 2020 Sep 8:JCO2001857. doi: 10.1200/JCO.20.01857.
    PubMed        
    
    

    
    J Natl Cancer Inst

33. JATOI I, Pinsky PF
    Breast Cancer Screening Trials: Endpoints and Over-diagnosis.
    J Natl Cancer Inst. 2020 Sep 8. pii: 5902831. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Lancet Oncol

34. BOURLOND F, Lipsker D
    Multiple brown papules at the site of mastectomy for breast cancer.
    Lancet Oncol. 2020;21:e460.
    PubMed        
    
    

    
    Nature

35. YEOW ZY, Lambrus BG, Marlow R, Zhan KH, et al
    Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.
    Nature. 2020 Sep 9. pii: 10.1038/s41586-020-2690.
    PubMed         Abstract available
    
    

    
    PLoS Genet

36. RATNAKUMAR A, Weinhold N, Mar JC, Riaz N, et al
    Protein-Protein interactions uncover candidate 'core genes' within omnigenic disease networks.
    PLoS Genet. 2020;16:e1008903.
    PubMed         Abstract available
    
    

    
    PLoS One

37. CUTLER W, Kolter J, Chambliss C, O'Neill H, et al
    Long term absence of invasive breast cancer diagnosis in 2,402,672 pre and postmenopausal women: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0237925.
    PubMed         Abstract available
    
    
38. PORTER W, Snowden E, Hahn F, Ferguson M, et al
    High accuracy gene expression profiling of sorted cell subpopulations from breast cancer PDX model tissue.
    PLoS One. 2020;15:e0238594.
    PubMed         Abstract available
    
    

    
    Radiology

39. MANN RM, Hooley R, Barr RG, Moy L, et al
    Novel Approaches to Screening for Breast Cancer.
    Radiology. 2020 Sep 8:200172. doi: 10.1148/radiol.2020200172.
    PubMed         Abstract available
    
    
40. ERIKSSON M, Czene K, Strand F, Zackrisson S, et al
    Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening.
    Radiology. 2020 Sep 8:201620. doi: 10.1148/radiol.2020201620.
    PubMed         Abstract available
    
    

    
    Semin Oncol

41. BREDIN P, Walshe JM, Denduluri N
    Systemic therapy for metastatic HER2-positive breast cancer.
    Semin Oncol. 2020 Aug 18. pii: S0093-7754(20)30085.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: